SUNFLOWER(300111)

Search documents
新股发行及今日交易提示-20251010





HWABAO SECURITIES· 2025-10-10 08:27
| http://www.cninfo.com.cn/new/disclosure/detail?stockCode=000718&announcementId=122467 | 000718 | 苏宁环球 | 6880&orgId=gssz0000718&announcementTime=2025 | -09-24 | | | --- | --- | --- | --- | --- | --- | | http://www.cninfo.com.cn/new/disclosure/detail?stockCode=601929&announcementId=122467 | 601929 | 吉视传媒 | 6547&orgId=9900022073&announcementTime=2025 | -09-24 | | | http://www.cninfo.com.cn/new/disclosure/detail?stockCode=002549&announcementId=122467 | 002549 | 凯美特气 | 6353&orgId=9900017827&announcementTime=20 ...
向日葵:公司严格按照监管相关规定履行信息披露义务
Zheng Quan Ri Bao· 2025-10-09 08:40
证券日报网讯向日葵10月9日在互动平台回答投资者提问时表示,公司披露的预案内容真实、准确、完 整,公司严格按照监管相关规定履行信息披露义务。 (文章来源:证券日报) ...
向日葵:公司经营未受关税影响
Zheng Quan Ri Bao· 2025-10-09 08:38
证券日报网讯向日葵10月9日在互动平台回答投资者提问时表示,公司密切关注市场环境及政策导向变 化,经营未受关税影响。 (文章来源:证券日报) ...
四川峨眉山:向日葵绽放迎客来
Ren Min Wang· 2025-10-06 03:22
四川峨眉山:向日葵绽放迎客来【3】 四川峨眉山:向日葵绽放迎客来【4】 四川峨眉山:向日葵绽放迎客来 四川峨眉山:向日葵绽放迎客来【2】 ...
医药生物行业今日涨1.40%,主力资金净流入9.84亿元
Zheng Quan Shi Bao Wang· 2025-09-30 08:50
Market Overview - The Shanghai Composite Index rose by 0.52% on September 30, with 19 out of 28 sectors experiencing gains, led by the non-ferrous metals and defense industries, which increased by 3.22% and 2.59% respectively [1] - The pharmaceutical and biological industry saw an increase of 1.40% [1] - The sectors with the largest declines were telecommunications and non-bank financials, which fell by 1.83% and 1.14% respectively [1] Capital Flow Analysis - The main capital outflow from the two markets totaled 32.303 billion yuan, with only four sectors seeing net inflows [1] - The defense industry had the highest net inflow of 2.059 billion yuan, while the non-ferrous metals sector followed with a net inflow of 1.984 billion yuan [1] - The non-bank financial sector experienced the largest net outflow, totaling 11.405 billion yuan, followed by telecommunications with a net outflow of 5.936 billion yuan [1] Pharmaceutical and Biological Sector Performance - The pharmaceutical and biological sector had a net inflow of 984 million yuan, with 310 out of 475 stocks rising, including two hitting the daily limit [2] - The top three stocks by net inflow were WuXi AppTec with 1.113 billion yuan, followed by Hengrui Medicine and Yong'an Pharmaceutical with 431 million yuan and 134 million yuan respectively [2] - Nine stocks in this sector saw net outflows exceeding 50 million yuan, with C Jianfa Zhi leading at 896.727 million yuan [3] Top Gainers in Pharmaceutical Sector - WuXi AppTec increased by 6.42% with a turnover rate of 2.86% and a main capital flow of 1.112 billion yuan [2] - Hengrui Medicine rose by 3.40% with a turnover rate of 0.91% and a main capital flow of 431 million yuan [2] - Yong'an Pharmaceutical saw a rise of 6.92% with a turnover rate of 16.56% and a main capital flow of 134 million yuan [2] Top Losers in Pharmaceutical Sector - C Jianfa Zhi decreased by 15.04% with a turnover rate of 52.49% and a main capital flow of -896.727 million yuan [3] - Xiangrikui rose by 2.00% but had a net outflow of 854.806 million yuan [3] - Jilin Aodong fell by 1.91% with a net outflow of 797.945 million yuan [3]
39只A股筹码大换手(9月29日)





Zheng Quan Shi Bao Wang· 2025-09-29 08:49
Market Overview - As of September 29, the Shanghai Composite Index closed at 3862.53 points, up 34.43 points, with a gain of 0.90% [1] - The Shenzhen Component Index closed at 13479.43 points, up 270.43 points, with a gain of 2.05% [1] - The ChiNext Index closed at 3238.01 points, up 86.48 points, with a gain of 2.74% [1] Stock Performance - A total of 39 A-shares had a turnover rate exceeding 20% on this day, indicating significant trading activity [1] - Notable stocks with high turnover rates include: - C Haocreat (301668) with a turnover rate of 62.30% and a closing price of 58.78 yuan, down 3.73% [1] - C Jianfa Zhi (301584) with a turnover rate of 61.32% and a closing price of 34.12 yuan, up 13.73% [1] - Jin Hua New Materials (920015) with a turnover rate of 53.44% and a closing price of 53.00 yuan, down 3.58% [1] - Other stocks with notable turnover rates include: - C United Motion (301656) at 41.80% and a closing price of 32.77 yuan, up 3.87% [1] - Zhongdian Xinlong (002298) at 39.78% and a closing price of 11.99 yuan, down 6.77% [1] - Chuling Information (300250) at 35.58% and a closing price of 26.40 yuan, up 20.00% [1] Additional Notable Stocks - Huijin Co., Ltd. (300368) had a turnover rate of 33.76% and closed at 19.08 yuan, up 20.00% [1] - Li Hexing (301013) closed at 30.75 yuan with a turnover rate of 33.58%, up 5.56% [1] - Other stocks with significant trading activity include: - Weili Transmission (300904) at 31.67% and a closing price of 85.80 yuan, up 8.24% [1] - Huarun Technology (002453) at 31.36% and a closing price of 7.90 yuan, down 10.02% [1]
一周牛熊股丨7股周涨超40%,最牛股周涨超60%
Di Yi Cai Jing· 2025-09-28 13:57
| 证券简称 | 周涨跌幅 | 证券简称 | 周淵跌幅 | | --- | --- | --- | --- | | 蓝丰生化 | 61.16% | 博瑞医药 | -38.36% | | 向日葵 | 57.86% | 香江控股 | -30.77% | | 聚辰股份 | 51.90% | 好太太 | -30.24% | | 长川科技 | 49.40% | 泰嘉士 | -27.82% | | 复洁环保 | 44.87% | ST创意 | -26.21% | | 上纬新材 | 44.81% | 吉视传媒 | -25.73% | | 品茗科技 | 44.01% | 金逸影视 | -23.88% | | 晶合集成 | 39.58% | 金浦钛业 | -23.15% | | 精艺股份 | 36.74% | 西藏旅游 | -22.93% | | 唯特偶 | 35.67% | 西域旅游 | -22.79% | (文章来源:第一财经) 数据显示,本周(9月22日至9月26日)共有21只个股涨幅超30%,7只个股涨超40%。 蓝丰生化本周涨幅居首,周涨幅达61.16%。向日葵、聚辰股份、长川科技周涨幅居前,分别为57.86%、51 ...
突发“黑天鹅”!刚刚,这一板块集体下跌
Mei Ri Jing Ji Xin Wen· 2025-09-26 03:36
Group 1 - President Trump announced new tariffs on various imported products, effective October 1, including a 25% tariff on heavy trucks, 50% on kitchen cabinets and related materials, 30% on imported furniture, and 100% on patented and branded drugs [1] - The tariffs on drugs will only be waived if companies are building pharmaceutical factories in the U.S., with "building" defined as breaking ground or being under construction [1] - The pharmaceutical industry is warned that high tariffs may increase costs and disrupt drug supply chains, potentially putting patients at risk [7] Group 2 - The U.S. has a high dependency on imported drugs, with 70% of its pharmaceutical supply coming from abroad, prompting the administration to encourage domestic production through tariffs [7] - Major pharmaceutical companies like Johnson & Johnson, GlaxoSmithKline, and Eli Lilly have announced plans to increase investments in U.S. production, with Johnson & Johnson committing $55 billion [7] - The long-term implications of the tariff policy may lead to increased drug costs for patients, as domestic production costs in the U.S. are significantly higher than in other countries [7][8]
医药股,集体下挫
Di Yi Cai Jing Zi Xun· 2025-09-26 02:10
Group 1 - The pharmaceutical sector in both A-shares and Hong Kong stocks experienced a collective decline on September 26 [1] - In A-shares, Sunflower dropped by 10%, while Guangsheng Tang and Aosaikang fell over 8%. Other companies like Jimin Health, Hanyu Pharmaceutical, Wanbangde, Hengrui Medicine, and Huiyu Pharmaceutical also saw declines [1] - In Hong Kong stocks, WuXi AppTec decreased by over 5%, BeiGene fell by more than 4%, and Fosun Pharma dropped nearly 2% [1]
突发“黑天鹅”!刚刚,集体下跌
Zhong Guo Ji Jin Bao· 2025-09-26 02:09
Core Viewpoint - The pharmaceutical sector in the Asia-Pacific market experienced a significant decline, with various indices showing notable drops, particularly in the weight loss drugs, innovative drugs, and CRO sectors [1][2]. Group 1: Market Performance - The A-share pharmaceutical and biotechnology sector saw a downturn, with weight loss drug index dropping by 1.56%, innovative drug index by 0.61%, and CRO index by 0.40% [2]. - Individual stocks such as Sunflower (向日葵) fell over 10%, while Aosaikang (奥赛康) and Guangshengtang (广生堂) also experienced significant declines of 9.02% and 6.56% respectively [3]. Group 2: Hong Kong and Japan Market Impact - The Hang Seng Biotechnology Index opened down nearly 2% and continued to decline, with companies like MicroPort Medical (微创医疗) and BeiGene (百济神州) showing notable drops of 5.47% and 4.75% respectively [4]. - In Japan, companies such as Sumitomo Pharma (住友制药) and Daiichi Sankyo (第一三共) also faced declines exceeding 4% and 3% respectively [4]. Group 3: External Factors - The recent announcement by U.S. President Trump regarding a new round of high tariffs on imported goods, including a punitive 100% tariff on patented and branded pharmaceuticals, is expected to impact the pharmaceutical industry significantly [5].